21268 ⎘
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient; Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
Formulations of bendamustine
#1802Diclofenac topical formulation
#1803Allantoin-containing skin cream
#1804Pharmaceutical composition for preventing or treating inflammatory diseases or infectious diseases, containing m-3M3FBS, which is activator of phospholipase C, as active ingredient
#1805Allantoin-containing skin cream
#1806Stable formulations for parenteral injection of small molecule drugs
#1807Allantoin-containing skin cream
#1808Topical formulations, systems and methods
#1809Oral formulations and lipophilic salts of methylnal trexone
#1810Lipids for therapeutic agent delivery formulations
#1811Cream composition enhancing skin absorption of glucosamine
#1812Cross-linked gelatin composition comprising a wetting agent
#1813PROLONGED RELEASE BIOADHESIVE THERAPEUTIC SYSTEMS
#1814Antimicrobial compositions and methods
#1815Fulvestrant formulations
#1816Foamable formulation
#1817Stable ready to use injectable paracetamol formulation
#1818Stabilized anthocyanin compositions
#1819Matrix composition for delivery of hydrophobic actives
#1820Compositions and methods for treating skin cancer associated diseases
#1821REDUCING VISCOSITY OF PHARMACEUTICAL FORMULATIONS
#1822Excipients for Stabilising Viral Particles, Polypeptides or Biological Material
#1823Anti-dandruff shampoo
#1824Pharmaceutical Product, Method of Production and Method of Application of the Pharmaceutical Product
#1825PAINTING THE PIA, ARACHNOID, AND SPINAL CORD PARENCHYMA
#1826PEG BASED HYDROGEL FOR PERIPHERAL NERVE INJURY APPLICATIONS AND COMPOSITIONS AND METHOD OF USE OF SYNTHETIC HYDROGEL SEALANTS
#1827Parenteral controlled release formulations of NSAID's
#1828COMPOSITION, METHOD, AND KIT FOR ALPHA-1 PROTEINASE INHIBITOR
#1829Stabilisation of viral particles
#1830Method for producing reservoir layer for hoof treatment and reservoir layer
#1831Delivery of nanoparticles to neurons
#1832Dermal delivery compositions and methods
#1833Nanoparticles and nanoparticle compositions
#1834METHOD AND AGENT FOR DETECTING DRUGS IN BEVERAGES
#1835Absorbable in situ gel-forming system, method of making and use thereof
#1836Topical formulation
#1837Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
#1838NOVEL AMPHIPHILES
#1839TOPICAL TRANSDERMAL DEXMEDETOMIDINE COMPOSITIONS AND METHODS OF USE THEREOF
#1840Treatment of pain with topical diclofenac
#1841SiRNA hydrogel and method for manufacturing the same
#1842Therapeutic foam
#1843Treatment of pain with topical diclofenac
#1844COMPOSITIONS AND METHODS USEFUL FOR REDUCING THE VISCOSITY OF PROTEIN-CONTAINING FORMULATIONS
#1845Treatment of pain with topical diclofenac compounds
#1846Liquid Formulations Of Bendamustine
#1847Solvent/polymer solutions as suspension vehicles
#1848Solvent/polymer solutions as suspension vehicles
#1849ALLANTOIN-CONTAINING SKIN CREAM
#185017-hydroxyprogesterone ester-containing oral compositions and related methods
#1851ALCOHOL FREE FORMULATION OF ARGATROBAN
#1852SNALP FORMULATIONS CONTAINING ANTIOXIDANTS
#1853Dermal delivery device with in situ seal
#1854Stabilised solid compositions of factor VII polypeptides
#1855Transdermal compositions of ibuprofen and methods of use thereof
#1856Mixture and infusion or drink solution
#1857Cross-linked compositions
#1858STABILIZED ANTHOCYANIN COMPOSITIONS
#1859Sanitizing compositions
#1860Pharmaceutical compositions for intranasal administration for the treatment of neurodegenerative disorders
#1861TOPICAL VASOCONSTRICTOR PREPARATIONS AND METHODS FOR PROTECTING CELLS DURING CANCER CHEMOTHERAPY AND RADIOTHERAPY
#1862Variants of C-type natriuretic peptide
#1863Phospholipid depot
#1864Highly permeating terbinafine formulation
#1865Human antibodies that bind human interleukin-12
#1866Diclofenac topical formulation
#1867METHOD AND PHARMACEUTICAL TO TREAT SPINAL DISCS
#1868Pharmaceutical composition comprising a GLP-1 agonist, an insulin and methionine
#1869PHARMACEUTICAL FORMULATION FOR PROTEINS
#1870COMPOSITIONS AND METHODS FOR ENHANCING CORTICOSTEROID DELIVERY
#1871Pharmaceutical composition comprising a GLP-1 agonist and methionine
#1872Stabilized anthocyanin compositions
#1873LIQUID STATIN FORMULATION
#1874Topical Compositions with Cannabis Extracts
#1875Solvent/polymer solutions as suspension vehicles
#1876STABLE TEMSIROLIMUS COMPOSITION AND PROCESS OF PREPARING SAME
#1877COMPOSITIONS OF OPIOID ANTAGONISTS AND METHODS FOR TREATING SCLERODERMA THEREWITH
#1878INSULIN PREPARATIONS CONTAINING METHIONINE
#1879Human antibodies that bind the P40 subunit of human IL-12 and methods for using the same
#1880Cross-linked gelatin composition coated with a wetting agent
#1881Stable formulations for parenteral injection of peptide drugs
#1882PROPYLENE GLYCOL-CONTAINING PEPTIDE FORMULATIONS WHICH ARE OPTIMAL FOR PRODUCTION AND FOR USE IN INJECTION DEVICES
#1883Coumarin compounds as melanogenesis modifiers and uses thereof
#1884Methods of treatment using human antibodies that bind IL-12
#1885Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin
#1886STABILIZED ANTHOCYANIN COMPOSITIONS
#1887Use of inhibitors of bruton's tyrosine kinase (Btk)
#1888Methods for Inhibiting Yellow Color Formation in a Composition
#1889Osmotic delivery comprising an insulinotropic peptide and uses thereof
#1890AGGREGATES WITH INCREASED DEFORMABILITY, COMPRISING AT LEAST THREE AMPHIPATS, FOR IMPROVED TRANSPORT THROUGH SEMI-PERMEABLE BARRIERS AND FOR THE NON-INVASIVE DRUG APPLICATION IN VIVO, ESPECIALLY THROUGH THE SKIN
#1891Biodegradable drug delivery compositions
#1892Combinations Comprising a VEGF Receptor Inhibitor
#1893Formulations of volatile anesthetics and methods of use for reducing inflammation
#1894METHODS FOR TREATING SKIN DISORDERS WITH TOPICAL NITROGEN MUSTARD COMPOSITIONS
#189517ALPHA, 21-DIHYDROXYPREGNENE ESTERS AS ANTIANDROGENIC AGENTS
#1896Composition for alleviating ultraviolet radiation-induced damage
#1897STABLE INJECTABLE COMPOSITIONS
#1898Combinations of adapalene and benzoyl peroxide for treating acne lesions
#1899Formulation of diclofenac
#1900COMPOSITIONS AND METHODS FOR TREATING FUNGAL INFECTION OF THE NAIL
#1901Liquid formulations of bendamustine
#1902Multicomponent degradable cationic polymers
#1903NOVEL ANTIBODY FORMULATION
#1904Sincalide Formulations
#1905Transdermal composition comprising tolterodine
#1906Combination/association of adapalene and benzoyl peroxide for treating acne lesions
#1907LYOPHILIZED FORMULATIONS FOR SMALL MODULAR IMMUNOPHARMACEUTICALS
#1908Pharmaceutical formulation containing gelling agent
#1909THE USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)
#1910NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS
#1911ANTIVIRAL TRANSDERMAL PATCH AND METHOD FOR PRODUCING THE SAME
#1912NANOPARTICULATE MEGESTROL FORMULATIONS
#1913USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)
#1914Botanical formulations
#1915Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
#1916Sensitive methods for detecting the presence of cancer associated with the over-expression of galectin-3 using biomarkers derived from galectin-3
#1917Topical drug delivery system with dual carriers
#1918Materials and methods for improving gastrointestinal function
#1919Topical drug delivery system with dual carriers
#1920Topical drug delivery system with dual carriers
#1921Therapeutic composition to treat lesions caused by herpes simplex virus
#1922Oral formulations and lipophilic salts of methylnaltrexone
#1923Topical drug delivery system with dual carriers
#1924ALLANTOIN-CONTAINING SKIN CREAM
#1925COMPOSITIONS FOR THE TREATMENT OF METASTATIC CANCER AND METHODS OF USE THEREOF
#1926COMBINATIONS OF ADAPALENE AND BENZOYL PEROXIDE FOR TREATING ACNE LESIONS
#1927Riluzole aqueous suspensions
#1928Paracetamol for parenteral administration
#1929STABILIZATION OF QUINOL COMPOSITION SUCH AS CATECHOLAMINE DRUGS
#1930Lipids and compositions for the delivery of therapeutics
#1931Compositions with reduced dimer formation
#1932Therapeutic Compositions for Treatment of Corneal Disorders
#1933Liquid composition of factor VII polypeptides
#1934Method for reducing pain
#1935Liquid, aqueous pharmaceutical compositions of factor VII polypeptides
#1936PHARMACEUTICAL COMPOSITION AND SYSTEM FOR PERMEABILIZING FETAL MEMBRANES
#1937Chemical Combination and Method for Increasing Delivery of Coenzyme Q10
#1938METHOD AND PHARMACEUTICAL TO TREAT SPINAL DISCS
#1939Sustained release of microcrystalline peptide suspensions
#1940Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds
#1941Lipids and compositions for the delivery of therapeutics
#1942Lipids and compositions for the delivery of therapeutics
#1943Method for enhancing penetration of lipid insoluble medicaments through cell membranes using small S-Allyl-containing molecules with phospholipid permeability as carrier molecules
#1944DRUG CONJUGATE COMPOSITION
#1945ENEMA PREPARATIONS AND THEIR USE
#1946Compositions with reduced hepatotoxicity
#1947Aqueous composition containing follicle-stimulating hormone and histidine
#1948CHEWABLE GELLED EMULSIONS
#1949Solvent/polymer solutions as suspension vehicles
#1950Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
#1951Compositions and methods for including melanogenesis in a subject
#1952IMPLANTABLE DEVICES FOR TREATING HIV
#1953Method for treating chronic wounds with an extracellular polymeric substance solvating system
#1954Chemical permeation enhancers enhance nerve blockade by toxins
#1955Gels for Transdermal Delivery
#1956STABLE CLEANSER COMPOSITIONS CONTAINING SULFUR
#1957Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy
#1958Stabilized anthocyanin Compositions
#1959Stabilized anthocyanin compositions
#1960COMPOSITIONS FOR CLEANING AND DISINFECTING NASAL TRACT AND SINUS CAVITY
#1961HFSH AQUEOUS FORMULATION
#1962LIQUID FORMULATIONS OF BENDAMUSTINE
#1963Formulations of bendamustine
#1964PHARMACEUTICAL COMPOSITIONS COMPRISING BORONIC ACID COMPOUNDS
#1965Formulation comprising GLP-1
#1966PHARMACEUTICAL PREPARATION COMPRISING AN ANTIBODY AGAINST THE EGF RECEPTOR
#1967Formulations of daptomycin
#1968ALLANTOIN-CONTAINING SKIN CREAM
#1969Directly injectable formulations which provide enhanced cryoprotection of cell products
#1970Volatile Anesthetic Compositions and Methods of Use
#1971NOVEL ANTIBODY FORMULATION
#1972ALLANTOIN-CONTAINING SKIN CREAM
#1973Nanosuspension of a poorly soluble drug via microfluidization process
#1974Stabilized anthocyanin compositions
#1975Method and composition for use in preparation of a patient for surgery
#1976LOW VISCOSITY COMPOSITIONS COMPRISING A PEGYLATED GLA-DOMAIN CONTAINING PROTEIN
#1977Cross-linked compositions
#1978Percutaneous absorption enhancer and transdermal preparation using the same
#1979Osmotic drug delivery devices containing suspension formulations comprising particles having active agents and nonaqueous single-phase vehicles
#1980Intracorporeal Medicaments for Photodynamic Treatment of Disease
#1981TOPICAL COMPOSITION FOR CONTROLLING ECTOPARASITES IN DOGS AND CATS
#1982Stabilized compositions of proteins having a free thiol moeity
#1983Antiseptic teat dip microemulsion
#1984Highly Concentrated Pharmaceutical Formulations
#1985Sodium channel blocker delivery system with scleral lens
#1986SODIUM CHANNEL BLOCKER DELIVERY SYSTEM WITH SCLERAL LENS
#1987Formulation for room temperature stabilization of a live attenuated bacterial vaccine
#1988Cardioplegia Solution for Cardiac Surgery
#1989LIQUID FORMULATION OF FSH
#1990TOPICAL PAIN FORMULATION
#1991Non-Aggregating Virus Formulation
#1992PHARMACEUTICALLY ACCEPTABLE FORMULATIONS/COMPOSITIONS FOR PEPTIDYL DRUGS
#1993Subcutaneous anti-HER2 antibody formulations and uses thereof
#1994Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief
#1995METHODS FOR TREATING SKIN DISORDERS WITH TOPICAL NITROGEN MUSTARD COMPOSITIONS
#1996Storage-stable formulation of paracetamol in aqueous solution
#1997Storage-stable formulation of paracetamol in aqueous solution
#1998PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCER AND OTHER DISEASES OR DISORDERS
#1999Prolonged release bioadhesive therapeutic systems
#2000Compositions and methods for preparing and using same
#2001Topical formulation
#2002IMMUNOSUPPRESSIVE MACROLIDE POWDER FOR ORAL SUSPENSION
#2003LYOPHILIZED PREPARATION OF STABILIZED ANTHRACYCLINE COMPOUNDS
#2004Method for reducing pain with ziconotide and baclofen
#2005Method for reducing pain with ziconotide and morphine
#2006Bendamustine amphiphilic anionic compositions
#2007Slow release compositions
#2008Method and pharmaceutical to treat spinal discs
#2009Myostatin inhibitor enhancement of musculoskeletal repair
#2010Therapeutic methods and pharmaceutical compositions for treating warts with tellurium compounds
#2011FORSYTHIASIDE INJECTION PREPARATION AND PREPARATIVE METHOD THEREOF
#2012Method for protection of peptides or proteins against non-enzymatic deamidation
#2013Pharmaceutical formulations
#2014Botanical anti-acne formulations
#2015SOLVENT/POLYMER SOLUTIONS AS SUSPENSION VEHICLES
#2016PHARMACEUTICAL FORMULATION CONTAINING RECOMBINANT HUMAN SERUM ALBUMIN-INTERFERON ALPHA FUSION PROTEIN
#2017Variants of C-type natriuretic peptide
#2018High concentration factor VII polypeptide formulations comprising an aromatic preservative and an antioxidant
#2019DERMAL DELIVERY DEVICE WITH ULTRASONIC WELD
#2020PHARMACEUTICAL SYSTEM FOR TRANS-MEMBRANE DELIVERY
#2021Pharmaceutical liquid composition of botulinum toxin with improved stability
#2022Compositions for the treatment of hoof diseases
#2023VACCINE
#2024High concentration antibody-containing liquid formulation
#2025SALTS OF ACTIVE INGREDIENTS WITH POLYMERIC COUNTER-IONS
#2026Stabilized lipid formulation of apoptosis promoter
#2027Methods of Treating Infections of the Nail
#2028VANCOMYCIN AND TEICOPLANIN ANHYDROUS FORMULATIONS FOR TOPICAL USE
#2029NANOPARTICULATE MEGESTROL FORMULATIONS
#2030LH liquid formulations
#2031CONTROLLED-RELEASE CLOZAPINE COMPOSITIONS
#2032DRUG DELIVERY COMPOSITION
#2033PHARMACEUTICAL FORMULATION OF TAXANE
#2034Dermal delivery device with reduced loss of its volatile components
#2035STABILIZED PHARMACEUTICAL COMPOSITION
#2036SUSTAINED RELEASE OF MICROCRYSTALLINE PEPTIDE SUSPENSIONS
#2037Compositions comprising A C2-C14 carboxylic acid and a surfactant for treating hoof diseases
#2038Antimicrobial Compositions And Related Methods
#2039Freeze-dried plasma formats for the trauma care field
#2040Nanoparticulate megestrol formulations
#2041Compositions and methods for enhancing corticosteroid delivery
#2042Compositions and methods for enhancing corticosteroid delivery
#2043COMPOSITIONS AND METHODS FOR ENHANCING CORTICOSTEROID DELIVERY
#2044SYNERGISTIC HERBAL COMPOSITION
#2045Therapeutic foam
#2046Method of preparing (+)-1,4-dihydro-7-[(3,4)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
#2047Compositions For Delivering A Drug
#2048Biphasic lipid-vesicle compositions
#2049COMPOSITION FOR TREATING ISCHEMIC LIMB DISEASE COMPRISING STEM CELLS DERIVED FROM ADIPOSE TISSUE
#2050Compositions For Delivering A Drug
#2051Methods for Treating or Preventing Radiocontrast Agent Induced Kidney Injury
#2052BODY FLUID EXPANDERS COMPRISING N-SUBSTITUTED AMINOSULFONIC ACID BUFFERS
#2053STABLE ANTIBODY COMPOSITIONS AND METHODS OF STABILIZING SAME
#2054Pharmaceutical formulation containing gelling agent
#2055FACTOR VIII FORMULATIONS
#2056Anti A beta antibody formulation
#2057Liquid, Aqueous Pharmaceutical Composition of Factor VII Polypeptides
#2058Apparatus and method for transdermal delivery of parathyroid hormone agents
#2059Apparatus for transdermal delivery of parathyroid hormone agents
#2060OXYGEN-CARRYING BLOOD SUBSTITUTE PREPARATIONS
#2061THIXOTROPIC PHARMACEUTICAL COMPOSITIONS
#2062USE OF A SURFACTANT FOR THE PREPARATION OF A FORMULATION FOR THE TREATMENT OF ADIPOSE DISEASES
#2063Protein formulations for use at elevated temperatures
#2064AQUEOUS SOLUTION PREPARATION CONTAINING CAMPTOTHECIN COMPOUNDS
#2065TARGETED INTRACELLULAR DELIVERY OF ANTIVIRAL AGENTS
#2066Apparatus and method for transdermal delivery of parathyroid hormone agents
#2067USE OF AN AQUEOUS MICRO-EMULSION FOR THE PREPARATION OF A FORMULATION FOR THE TREATMENT OF ADIPOSE DISEASES
#2068Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one
#2069ANTI-TUMOR COMPOSITION COMPRISING TISSUE-ACCUMULATING CHITOSAN GEL
#2070COMPOSITIONS AND METHODS FOR ENHANCING TRANSMUCOSAL DELIVERY
#2071ALCOHOL FREE FORMULATION OF ARGATROBAN
#2072Prevention and Treatment of Ophthalmic Complications of Diabetes
#2073EJECTION LIQUID AND EJECTION METHOD
#2074Process for Preparation of a Stable Dispersion of Solid Amorphous Submicron Particles in an Aqueous Medium
#2075COMPOSITIONS AND METHODS FOR THE PREVENTION OF OXIDATIVE DEGRADATION OF PROTEINS
#2076Method and topical formulation for treating localized edema
#2077Liquid, aqueous pharmaceutical compositions of factor VII polypeptides
#2078Sincalide Formulations
#2079STABILIZATION OF AQUEOUS COMPOSITIONS OF PROTEINS WITH DISPLACEMENT BUFFERS
#2080STABILIZED PHARMACEUTICAL COMPOSITION CONTAINING DONEPEZIL, PROCESS OF PRODUCING SAME AND METHOD FOR STABILIZATION
#2081Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
#2082LIQUID PREPARATION
#2083Controlled release copolymer formulation with improved release kinetics
#2084Transdermal hormone delivery system: compositions and methods
#2085Protein formulations for use at elevated temperatures
#2086Transdermal hormone delivery system: compositions and methods
#2087Combinations of adapalene and benzoyl peroxide for treating acne lesions
#2088Compositions with enhanced elasticizing activity
#2089Method for administering GLP-1 molecules
#2090Composition and method for preparing plasminogen
#2091ANTIVIRAL FORMULATION
#2092HUMAN ANTIBODIES THAT BIND HUMAN IL-12 AND METHODS FOR PRODUCING
#209317α, 21-dihydroxypregnene esters as antiandrogenic agents
#2094Arylsulfanyl compounds and compositions for delivering active agents
#2095Combinations of adapalene and benzoyl peroxide for treating acne lesions
#2096Pharmaceutical compositions
#2097Pharmaceutical formulations for reducing pain
#2098Fulvestrant formulations
#2099Injectable liquid paracetamol formulation
#2100COMPOSITIONS AND METHODS FOR THE TREATMENT OF BLADDER CANCER